QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)

Nu Skin Enterprises Stock Price, News & Analysis (NYSE:NUS)

$17.61
+0.05 (+0.28%)
(As of 12/4/2023 ET)
Compare
Today's Range
$17.43
$18.04
50-Day Range
$16.33
$21.56
52-Week Range
$16.15
$45.55
Volume
441,070 shs
Average Volume
587,593 shs
Market Capitalization
$870.11 million
P/E Ratio
14.92
Dividend Yield
8.86%
Price Target
$29.50

Nu Skin Enterprises MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
67.5% Upside
$29.50 Price Target
Short Interest
Healthy
4.09% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.56
Upright™ Environmental Score
News Sentiment
-0.14mentions of Nu Skin Enterprises in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$390,992 Sold Last Quarter
Proj. Earnings Growth
35.43%
From $1.75 to $2.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.17 out of 5 stars

Consumer Staples Sector

3rd out of 134 stocks

Drugs, Proprietaries, & Sundries Industry

1st out of 7 stocks


NUS stock logo

About Nu Skin Enterprises Stock (NYSE:NUS)

Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

NUS Stock Price History

NUS Stock News Headlines

Nu Skin Opens New Manufacturing Facility in China
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Nu Skin: Is It Just A Growth Problem?
5 Worst Performing Dividend Stocks YTD
Q2 2023 NU Skin Enterprises Inc Earnings Call
12 Best Dividend Stocks Under $30
See More Headlines
Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 9/6 Dividend
8/24/2023
Dividend Payable
9/06/2023
Last Earnings
11/01/2023
Ex-Dividend for 12/6 Dividend
11/22/2023
Today
12/04/2023
Dividend Payable
12/06/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/21/2024

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Personal Products
CUSIP
67018T10
Employees
3,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$29.50
High Stock Price Target
$39.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+67.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Net Income
$104.78 million
Pretax Margin
2.08%

Debt

Sales & Book Value

Annual Sales
$2.23 billion
Cash Flow
$4.44 per share
Book Value
$18.13 per share

Miscellaneous

Free Float
48,026,000
Market Cap
$870.60 million
Optionable
Optionable
Beta
1.12
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Steven J. Lund (Age 70)
    Executive Chairman of the Board
    Comp: $659.21k
  • Mr. Ryan S. Napierski (Age 49)
    President, CEO & Director
    Comp: $1.28M
  • Dr. Joseph Y. Chang Ph.D. (Age 70)
    Executive VP & Chief Scientific Officer
    Comp: $907.04k
  • Mr. Chayce David Clark (Age 40)
    Executive VP & General Counsel
    Comp: $593.66k
  • Ms. Mang Yee Tang (Age 52)
    Strategic Advisor
    Comp: $769.56k
  • Mr. Blake M. Roney (Age 64)
    Founder
    Comp: $621.69k
  • Ms. Sandra N. Tillotson (Age 66)
    Founder
    Comp: $1.06M
  • Mr. James D. Thomas (Age 44)
    Executive VP, Chief Accounting Officer & CFO
  • Mr. Joe Sueper
    Senior VP & CTO
  • Mr. Mark L. Adams (Age 71)
    Chief Information Officer














NUS Stock Analysis - Frequently Asked Questions

Should I buy or sell Nu Skin Enterprises stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NUS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View NUS analyst ratings
or view top-rated stocks.

What is Nu Skin Enterprises' stock price target for 2024?

4 brokerages have issued 1 year target prices for Nu Skin Enterprises' shares. Their NUS share price targets range from $23.00 to $39.00. On average, they anticipate the company's stock price to reach $29.50 in the next year. This suggests a possible upside of 67.5% from the stock's current price.
View analysts price targets for NUS
or view top-rated stocks among Wall Street analysts.

How have NUS shares performed in 2023?

Nu Skin Enterprises' stock was trading at $42.16 at the beginning of the year. Since then, NUS shares have decreased by 58.2% and is now trading at $17.61.
View the best growth stocks for 2023 here
.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 2,300,000 shares, an increase of 28.5% from the October 15th total of 1,790,000 shares. Based on an average daily trading volume, of 571,300 shares, the days-to-cover ratio is currently 4.0 days. Currently, 4.7% of the shares of the company are short sold.
View Nu Skin Enterprises' Short Interest
.

When is Nu Skin Enterprises' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 21st 2024.
View our NUS earnings forecast
.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its earnings results on Wednesday, November, 1st. The company reported $0.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.64 by $0.08. The company earned $498.80 million during the quarter, compared to the consensus estimate of $520.09 million. Nu Skin Enterprises had a net margin of 2.92% and a trailing twelve-month return on equity of 13.44%. The company's quarterly revenue was down 7.3% on a year-over-year basis. During the same period last year, the business posted $0.47 EPS.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Wednesday, November 1st. Investors of record on Friday, November 24th will be paid a dividend of $0.39 per share on Wednesday, December 6th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 8.86%. The ex-dividend date of this dividend is Wednesday, November 22nd.
Read our dividend analysis for NUS
.

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises (NYSE:NUS) pays an annual dividend of $1.56 per share and currently has a dividend yield of 8.88%. NUS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 23 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 132.20%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, NUS will have a dividend payout ratio of 65.82% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NUS.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises updated its FY23 earnings guidance on Wednesday, November, 1st. The company provided earnings per share guidance of $1.62-1.77 for the period, compared to the consensus EPS estimate of $2.36. The company issued revenue guidance of $1.92-1.96 billion, compared to the consensus revenue estimate of $2.05 billion.

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife (HLF), Mastercard (MA) and Netflix (NFLX).

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by many different institutional and retail investors. Top institutional shareholders include Invesco Ltd. (3.43%), Morgan Stanley (2.23%), Charles Schwab Investment Management Inc. (1.97%), Bank of New York Mellon Corp (1.54%), Northern Trust Corp (1.12%) and Victory Capital Management Inc. (0.92%). Insiders that own company stock include Andrew D Lipman, D Matthew Dorny, Edwina D Woodbury, Emma S Battle, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Laura Nathanson, Mark H Lawrence, Ritch N Wood, Ryan S Napierski, Steven Keith Hatchett and Steven Lund.
View institutional ownership trends
.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:NUS) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -